SA’s biggest generic drug maker, Aspen Pharmacare, is advocating for the establishment of a pooled procurement mechanism for African pharmaceuticals, arguing that it will improve security of supply and widen access to life-saving vaccines and medicines.

Africa’s vulnerability to global pharmaceutical shortages was thrown into sharp relief during the coronavirus pandemic, as the continent’s nations were relegated to the back of the queue when Covid-19 vaccines were in short supply. Africa imports 99% of its vaccines, and countries with domestic production capacity prioritised their own populations before selling Covid-19 jabs to the continent...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.